Navigation Links
Seizures in Medical Technology

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

... challenge and up to 40% of patients with partial seizures do not achieve seizure control with ... 1200mg) was effective in reducing partial-onset seizures in patients not controlled with one of the most ... to patients with partial-onset seizures who are not adequately controlled with their ...

Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults

... who still have uncontrolled partial onset seizures with current treatment ATLANTA, May 26 ... add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and ... than 30% of patients will continue to experience seizures despite trying two or more AEDs ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase ... CONSTA(R) does not affect them adversely. seizures : RISPERDAL(R) CONSTA(R) should be used cautiously in patients with a history of seizures or with conditions that potentially lower seizure ...

VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful

... findings that show people with epilepsy, whose seizures have been controlled with a consistent drug ... than 1,000 people with epilepsy, reveals that seizures worsened for 59 percent of people who had ... for 49 percent of that same group. Additionally, seizures worsened for 15 percent of those who had switched ...

Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects

... Diazepam for the Treatment of Acute Repetitive seizures in Epilepsy - Phase II Trials on Both ... in Parkinson's disease and Acute Repetitive seizures ("ARS") in refractory epilepsy ... and rectal forms for the treatment of epileptic seizures including ...

New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures

... treatment for people with partial-onset seizures who are 16 years of age and older. "In ... Formulations in Adults with Partial-Onset seizures Poster Session 3, Monday, December 8, 8:00 ... therapy in the treatment of partial onset seizures in patients 16 years of age and older with ...

Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures

... FDA for the adjunctive treatment of partial onset seizures (POS) in patients 16 years of age and older, was ... Adjunctive Therapy of Partial Onset seizures in Adults Two identically designed, ... name of COMFYDE(TM). About Partial Onset seizures and Epilepsy Epilepsy is one of the most ...

Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy

... retigabine significantly reduced the number of seizures in adult patients with refractory partial-onset ... a statistically significant reduction in seizures compared to placebo at all three doses when added ... affected by the disturbance. Primary generalized seizures involve the entire brain from the outset, while ...

New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy

... an important treatment option for patients whose seizures are not adequately controlled with existing ... Agency) for the treatment of partial-onset seizures with or without secondary generalisation in ... Patients had a history of at least four partial seizures per month despite treatment with up to three ...

FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months

... 10 years of age and older with partial onset seizures or generalized tonic-clonic seizures. It also is ... (aged two and above) with partial onset seizures or generalized tonic-clonic seizures, and in ... as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut ...

Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%

... by multiple types of treatment-resistant seizures and high rates of seizure-related injury. ... pediatric epilepsy usually resulting in multiple seizures occurring several times a day and is often ... they had a diagnosis of inadequately controlled seizures associated with LGS (including both atypical ...

Keppra XR(TM) Extended-Release Tablets Filed with the FDA

... in the adjunctive treatment of partial onset seizures in adults with epilepsy ATLANTA, Jan. 16 ... in the adjunctive treatment of partial onset seizures in adults with epilepsy has been accepted for ... The median percent reduction of partial onset seizures in the extended-release levetiracetam group ...

UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets

... reduced the frequency of partial onset seizures in patients with uncontrolled epilepsy and was ... The median percent reduction of partial onset seizures in the extended-release levetiracetam group ... of patients had 100% reduction in partial onset seizures and 8.9% were free from any type of seizure ...

New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy

... Extended-Release Formulation Reduced seizures in Patients Who Were ... significantly reduced the frequency of partial seizures in inadequately controlled patients with ... of the brain. Secondarily generalized seizures start out affecting only one side of the brain ...

Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy

... (EMEA) for use as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. "When patients are temporarily hospitalized or ... the EMEA for use as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy and is currently under review. Applications for ...

Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain

... pain and as adjunctive therapy for the treatment of partial onset seizures in adults with epilepsy. "Neuropathy can be a painful and potentially ... for its potential as adjunctive therapy to treat partial onset seizures in adults with epilepsy. Lacosamide oral tablet has been filed with the ...

Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate

... intranasal spray for the treatment of recurrent acute repetitive seizures in patients with epilepsy. Jazz Pharmaceuticals previously completed ... Recurrent Acute Repetitive Seizures Recurrent acute recurrent repetitive seizures (ARS) are bouts of acute seizure activity occurring within a 24-hour ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... doing things that require you to be alert. INVEGA((R)) SUSTENNA(TM) should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Call your doctor right away if you start thinking about suicide or ...

New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your ...

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

... professional. Avoid alcohol while on paliperidone. Paliperidone should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Extrapyramidal Symptoms (EPS) are usually persistent movement ...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

... professional. Avoid alcohol while on paliperidone. Paliperidone should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Extrapyramidal Symptoms (EPS) are usually persistent movement ...

Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your ...

New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria

... antibacterial or anticonvulsant therapy should be considered if serum valproic acid concentrations cannot be maintained in the therapeutic range or seizures occur. Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents and may range in severity ...

Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE. Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction ...

National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births

... instance of cerebral palsy related to premature birth. Magnesium sulfate is traditionally used in obstetrics to stop premature labor and prevent seizures in women with hypertension. The BEAM trial studied the link between magnesium sulfate and cerebral palsy by identifying 2,240 women who were likely ...

FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia

... antibacterial or anticonvulsant therapy should be considered if serum valproic acid concentrations cannot be maintained in the therapeutic range or seizures occur. Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents and may range in severity ...

New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease

... of symptoms and how the disease manifests itself can vary from person to person. One person may suffer difficulty breathing, have uncontrollable seizures and/or digestive problems, while another may not be able to walk, talk, see or hear. "The demonstration by Dr. Chinnery and colleagues that at ...

Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day

... Suppression of growth has been reported with long-term use of stimulants. Stimulants should be used with caution in patients with a prior history of seizures or EEG abnormalities. Difficulties with accommodation and blurring of vision have been reported with stimulant treatment. (See WARNINGS.) Focalin ...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

... if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE. Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction ...

Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your ...

New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain

... target -- collapsin-response mediator protein-2 (CRMP-2). Lacosamide is also being investigated for its potential to treat partial onset seizures in adults with epilepsy. Lacosamide oral tablet has been filed with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency ...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

... bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops ...

Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study

... away partially or completely if therapy is stopped. Risperidone and RLAI should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures. Risperidone, RLAI, and similar medications can raise the blood levels of ...

Status of the E2007 (perampanel) Development Program

... in the placebo arm. Eisai is preparing to initiate global Phase III studies with perampanel as add-on therapy in patients with refractory partial seizures in the first quarter of fiscal year 2008. The regulatory submission is planned for fiscal year 2012. Several pre-clinical models have also ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)

... which would predispose them to hypotension. As with other antipsychotic drugs, ABILIFY should be used with caution in patients with a history of seizures or with conditions that lower the seizure threshold. Like other antipsychotics, ABILIFY may have the potential to impair judgment, thinking, or ...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

... if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE. Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction ...

AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

... in any patient if the absolute neutrophil count is < 1000/mm. Warnings and Precautions also include the risk of orthostatic hypotension, cataracts, seizures and hyperlipidemia. Examination of the lens by methods adequate to detect cataract formation, such as slit lamp exam or other appropriately sensitive ...

Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration

... or hopelessness) or bipolar disorder; has abnormal thought or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if your child develops ...
Other Contents
(Date:8/21/2014)... BATON ROUGE In a finding that has implications ... and planets elsewhere in the solar system, LSU Associate ... funded by the National Science Foundation, or NSF, this ... sediments of a lake that lies 800 meters (2600 ... sheet support "viable microbial ecosystems.", Given that more than ...
(Date:8/21/2014)... A study recently published in the journal Carcinogenesis ... a new role for the protein adenomatous polyposis coli ... of cancer-related deaths in the U.S. , Lead author ... Biosciences and co-leader of the Cancer Biology program at ... of her career trying to understand the various activities ...
(Date:8/21/2014)... State University have developed a novel and versatile modeling ... for creating new materials as well as for studying ... allows us to model much larger and more complex ... says Nan Li, lead author of a paper on ... Department of Materials Science and Engineering. "This is a ...
Breaking Biology News(10 mins):800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Researchers develop models to study polyelectrolytes, including DNA and RNA 2
(Date:8/22/2014)... 22, 2014 Pirate Jonny's ... products in providing new recipe cards, fun t-shirts, and ... , Hailing from Clearwater, Florida, Pirate Jonny, aka, Jonathan ... card with two to three recipes featuring different flavors ... on the website. The recipe cards will ...
(Date:8/22/2014)... August 22, 2014 Until now, those with ... crutches or walkers to keep mobile. Thanks to an inventor ... much more effective. , He developed a prototype for the ... injured leg or foot but provide comfort and reduce pain ... different heights, it is also convenient and easy to install ...
(Date:8/22/2014)... 2014 The report "Higher Education ... & Compliance, Campus Technology, Student & Curriculum, Performance ... defines and segments the global Higher Ed market ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
(Date:8/22/2014)... Institutet in Sweden provides insight on how the brain ... from different sources and sides of the body, in ... which are presented in the journal Neuron , ... integrating various types of sensory information, with specialised functional ... is the main input structure in the basal ganglia, ...
(Date:8/22/2014)... dramatic images of nurses at New York University,s Langone ... carrying many including the youngest and most vulnerable down ... the storm surge generated by Hurricane Sandy. , ... York University Colleges of Nursing (NYUCN) and of Dentistry ... examines the impact on NYULMC nurses, post-Sandy deployment ...
Breaking Medicine News(10 mins):Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:The striatum acts as hub for multisensory integration 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3
Other TagsOther Tags